Essex Bio-Technology's total assets for Q2 2025 were HK$3.23B, an increase of 8.40% from the previous quarter. HK:1061 total liabilities were HK$959.94M for the fiscal quarter, a 11.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.